Blue Square Asset Management’s Biogen BIIB Stock Holding History

Blue Square Asset Management’s Portfolio BIIB Stock Details BIIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-3,044	Closed	-$861K	–	86
2021 Q3	$861K	Sell	3,044 -26	-0.8%	-$8.52K	0.54%	56
2021 Q2	$1.06M	Sell	3,070 -3,640	-54%	-$1.1M	0.65%	41
2021 Q1	$1.88M	Buy	6,710 +346	+5%	+$93.3K	1.2%	19
2020 Q4	$1.56M	Buy	6,364 +1,968	+45%	+$508K	1.04%	22
2020 Q3	$1.25M	Buy	4,396 +1,396	+47%	+$389K	0.86%	34
2020 Q2	$803K	Sell	3,000 -542	-15%	-$163K	0.55%	41
2020 Q1	$1.12M	Buy	3,542 +776	+28%	+$235K	1.04%	29
2019 Q4	$821K	Buy	2,766 +8	+0.3%	+$2.22K	0.64%	41
2019 Q3	$642K	Buy	+2,758	New	+$642K	0.5%	46

Other funds holding BIIB

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Blue Square Asset Management's BIIB Position: Q4 2021 in Review

Blue Square Asset Management sold out of Biogen (BIIB) in Q4 2021, closing a stake of 3,044 shares — an estimated $861K sold.

Blue Square Asset Management first reported a position in BIIB in Q3 2019 and held it in 9 quarters. The position peaked at $1.88M in Q1 2021. 1,009 funds tracked by Wall St. Rank hold BIIB as of Q4 2021.

Blue Square Asset Management reported no remaining Biogen position as of Q4 2021 after selling out during the quarter.
Blue Square Asset Management sold 3,044 Biogen shares in Q4 2021, an estimated $861K.
Blue Square Asset Management first reported a position in Biogen in Q3 2019 and held it in 9 quarters.
Blue Square Asset Management's Biogen position peaked at $1.88M in Q1 2021.
1,009 funds tracked by Wall St. Rank held Biogen as of Q4 2021.

Based on Blue Square Asset Management's 13F filing for Q4 2021, filed 9 Feb 2022.